Skip to content

Clinical trials

Lymphatic Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphatic Metastasis Clear all

209 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20051
20062
20071
20081
20092
20104
20113
20124
20132
20148
201510
201611
20174
201819
201915
202015
202117
202218
202317
202422
202512
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Unknown status61
Recruiting41
Not yet recruiting19
Active, not recruiting8
Terminated5
Enrolling by invitation5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University8
Fudan University6
Radboud University Medical Center6
Cancer Institute and Hospital, Chinese Academy of Medical Sciences5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
Maastricht University Medical Center4
Fifth Affiliated Hospital, Sun Yat-Sen University3
IRCCS San Raffaele3
Jichao Qin3
Odense University Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphatic Metastasis209
Breast Neoplasms27
Prostatic Neoplasms16
Stomach Neoplasms14
Thyroid Cancer, Papillary13
Colonic Neoplasms11
Thyroid Neoplasms10
Colorectal Neoplasms9
Neoplasm Metastasis9
Rectal Neoplasms9

Trials

Showing 51 to 75 of 209. Each trial links to its page on Pharma Observatory.

109 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.